Lymph node metastasis in early gastric adenocarcinoma in the United States of America

Abstract

Background and study aims Localized approaches are being increasingly used in the management of early gastric adenocarcinoma; however, there are limited data on lymph node metastasis in the US population. This study examined the incidence and predictors of lymph node involvement for early-stage gastric adenocarcinomas in the USA.

Patients and methods Data were abstracted from the national SEER database from 2004 to 2013. Exclusion criteria included: cases with unknown tumor characteristics, unknown patient characteristics, metastatic disease, neoadjuvant radiation, and lack of surgical resection or lymph node evaluation. Univariate and multivariable analyses were conducted to assess the relationship of tumor stage, grade, and size, and patient sex, race, and age with nodal involvement.

Results 43 769 cases of gastric adenocarcinoma were initially abstracted. After exclusions, 1577 patients remained for analysis. Multivariable analysis revealed that tumor stage (P < 0.001), grade (P = 0.008), and size (P < 0.001) were independent predictors of nodal metastasis. For low grade T1a tumors, nodal metastasis was present in 1.7 %, 1.7 %, 4.5 %, 4.1 %, and 20 % of tumors 0 – 1 cm, 1 – 2 cm, 2 – 3 cm, 3 – 4 cm, and ≥ 4 cm in size, respectively (P < 0.001), and in 8.4 %, 18.0 %, 19.5 %, 22.0 %, and 35.8 % of T1b tumors, respectively (P < 0.001).

Conclusions Low grade T1a tumors < 4 cm in size have low rates of nodal metastasis in the US population and may warrant consideration for local resection. Larger, higher grade T1b tumors have high rates of nodal metastasis in the US population and lymph node dissection may be indicated for patients who are surgical candidates.

• References

• 1 World Health Organization. Cancer fact sheet. 02/2017 Available from: http://www.who.int/mediacentre/factsheets/fs297/en/ (Accessed: 30 July 2017)
• 2 Karimi P, Islami F, Anandasabapathy S. et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014; 23: 700-713
• 3 Song M, Kang D, Yang JJ. et al. Age and sex interactions in gastric cancer incidence and mortality trends in Korea. Gastric Cancer 2015; 18: 580-589
• 4 Rahman R, Asombang AW, Ibdah JA. Characteristics of gastric cancer in Asia. World J Gastroenterol 2014; 20: 4483-4490
• 5 Shen L, Shan YS, Hu HM. et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 2013; 14: e535-e547
• 6 Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther 2014; 40: 250-260
• 7 Zheng Z, Zhang Y, Zhang L. et al. A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients. BMC Cancer 2016; 16: 92
• 8 Green PH, O'Toole KM, Slonim D. et al. Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am J Med 1988; 85: 658-661
• 9 McCall MD, Graham PJ, Bathe OF. Quality of life: A critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol 2016; 22: 1101-1113
• 10 Shin N, Jeon TY, Kim GH. et al. Unveiling lymph node metastasis in early gastric cancer. World J Gastroenterol 2014; 20: 5389-5395
• 11 Wang S, Zhang Z, Liu M. et al. Endoscopic resection compared with gastrectomy to treat early gastric cancer: A systematic review and meta-analysis. PLoS One 2015; 10: e0144774
• 12 Gamboa AM, Kim S, Force SD. et al. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement. Cancer 2016; 122: 2150-2157
• 13 Ahmad R, Setia N, Schmidt BH. et al. Predictors of lymph node metastasis in Western early gastric cancer. J Gastrointest Surg 2016; 20: 531-538
• 14 Choi AH, Nelson RA, Merchant SJ. et al. Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations. Gastrointestinal Endosc 2016; 83: 1184-1192
• 15 Ajani JA, D'Amico TA. National Comprehensive Cancer Network Gastric Cancer Guidelines. National Comprehensive Cancer Network; 2017 Version 5.2017. Available from: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf Accessed 10/26/2017
• 16 Washington K. 7th Edition of the AJCC Cancer Staging Manual: Stomach. Ann Surg Oncol 2010; 17: 3077-3079
• 17 Wong J, Jackson P. Gastric cancer surgery: an American perspective on the current options and standards. Curr Treat Options Oncol 2011; 12: 72-84
• 18 Pyo JH, Lee H, Min BH. et al. Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: A non-inferiority-matched cohort study. Am J Gastroenterol 2016; 111: 240-249
• 19 Meng FS, Zhang ZH, Wang YM. et al. Comparison of endoscopic resection and gastrectomy for the treatment of early gastric cancer: a meta-analysis. Surg Endosc 2016; 30: 3673-3683
• 20 Gotoda T, Yanagisawa A, Sasako M. et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3: 219-225
• 21 Kang HJ, Kim DH, Jeon TY. et al. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection. Gastrointest Endosc 2010; 72: 508-515
• 22 Choi KK, Bae JM, Kim SM. et al. The risk of lymph node metastases in 3951 surgically resected mucosal gastric cancers: implications for endoscopic resection. Gastrointest Endosc 2016; 83: 896-901
• 23 Willingham FF, Garud SS, Davis SS. et al. Human hybrid endoscopic and laparoscopic management of mass lesions of the foregut (with video). Gastrointest Endosc 2012; 75: 905-912
• 24 Garud SS, Keilin S, Cai Q. et al. Diagnosis and management of Barrett's esophagus for the endoscopist. Therap Adv Gastroenterol 2010; 3: 227-238
• 25 Garud SS, Willingham FF. Natural orifice transluminal endoscopic surgery. Gastrointest Endosc 2012; 76: 491-495